Trial Outcomes & Findings for Skin Care for Cancer Patients: A Product Satisfaction Survey (NCT NCT00871429)
NCT ID: NCT00871429
Last Updated: 2015-03-17
Results Overview
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
99 participants
Primary outcome timeframe
one month of use
Results posted on
2015-03-17
Participant Flow
Participants in this study will be patients seen at the Northwestern University SERIES clinic or Lurie Cancer Center who are receiving chemotherapeutic and or radiation treatments.
Participant milestones
| Measure |
Lindi Skin Participant Flow
|
|---|---|
|
Overall Study
STARTED
|
99
|
|
Overall Study
COMPLETED
|
75
|
|
Overall Study
NOT COMPLETED
|
24
|
Reasons for withdrawal
| Measure |
Lindi Skin Participant Flow
|
|---|---|
|
Overall Study
Lost to Follow-up
|
6
|
|
Overall Study
Withdrawal by Subject
|
17
|
|
Overall Study
Questionnaire not completed
|
1
|
Baseline Characteristics
Skin Care for Cancer Patients: A Product Satisfaction Survey
Baseline characteristics by cohort
| Measure |
Cancer Patients Using Lindi Skin Products
n=99 Participants
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=99 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
99 Participants
n=99 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=99 Participants
|
|
Sex: Female, Male
Female
|
94 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
5 Participants
n=99 Participants
|
|
Region of Enrollment
United States
|
99 participants
n=99 Participants
|
PRIMARY outcome
Timeframe: one month of usePopulation: the number of participants for analysis was determined per protocol.
Outcome measures
| Measure |
Lindi Skin Soothing Balm (Product A)
n=75 Participants
|
Lindi Skin Face Wash (Product C)
n=75 Participants
|
Lindi Skin Face Serum (Product B)
n=75 Participants
|
|---|---|---|---|
|
Product Satisfaction of the Following Test Articles A, B, and C: Lindi Skin Soothing Balm (Product A), Lindi Skin Face Serum (Product B), and Lindi Skin Face Wash (Product C)
Participant Product Satisfaction: Very Good/Good
|
78.67 Percentage of Participants
|
73.68 Percentage of Participants
|
88.31 Percentage of Participants
|
|
Product Satisfaction of the Following Test Articles A, B, and C: Lindi Skin Soothing Balm (Product A), Lindi Skin Face Serum (Product B), and Lindi Skin Face Wash (Product C)
Participant Product Satisfaction: OK
|
16.00 Percentage of Participants
|
23.68 Percentage of Participants
|
9.09 Percentage of Participants
|
|
Product Satisfaction of the Following Test Articles A, B, and C: Lindi Skin Soothing Balm (Product A), Lindi Skin Face Serum (Product B), and Lindi Skin Face Wash (Product C)
Participant Product Satisfaction: Bad/Very Bad
|
5.33 Percentage of Participants
|
2.63 Percentage of Participants
|
2.60 Percentage of Participants
|
SECONDARY outcome
Timeframe: one monthOutcome measures
Outcome data not reported
Adverse Events
Lindi Skin Soothing Balm (Product A)
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Lindi Skin Face Wash (Product C)
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Lindi Skin Face Serum (Product B)
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place